Thu.Oct 03, 2024

article thumbnail

Brain-computer interfaces are rapidly evolving. Here are six scientists shaping the field

STAT

Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex , allowing the man with no limb movement to control objects using his thoughts, the brain-computer interface field looks dramatically different — both the people doing the research and the technologies they are creating.  Researchers like Leigh Hochberg and Eddie Chang and big-name startups such as Synchron and Paradromics have turned what was not too long ago an arcane academi

361
361
article thumbnail

Flu vaccination rates are falling despite record child deaths. Can innovation save the day?

PharmaVoice

As respiratory disease season approaches, experts are concerned about vaccination rates — but the industry is churning out new solutions to help.

Vaccines 217
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Scientists may have found the reason why people with schizophrenia hear voices

STAT

Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published Thursday. People with schizophrenia often “hear” voices and sounds even when there are none — up to 80% of people with the mental illness have auditory hallucinations.

354
354
article thumbnail

IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients

Pharma Times

Phase 1 trial of IRL757 demonstrates good absorption and safety profile

129
129
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Epic and Particle dragged a nonprofit into their antitrust fight. Here’s what you need to know

STAT

From its founding days, Carequality knew that overseeing the flow of sensitive patient information in U.S. health care would be a tricky business. But the data exchange nonprofit with a staff of five probably never imagined finding itself in the middle of one of the biggest, and ugliest, antitrust fights in recent memory.  On one side is one of its biggest and most influential users: the nation’s largest electronic health records vendor, Epic Systems.

346
346
article thumbnail

FDA makes end of Zepbound, Mounjaro shortage official

BioPharma Dive

Removal of Lilly’s in-demand drugs from the FDA’s shortage list ramps up pressure on the companies selling compounded versions.

More Trending

article thumbnail

ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study

Pharma Times

Largest real-world study demonstrates significant survival advantage

122
122
article thumbnail

STAT+: UnitedHealth sues Medicare to reverse downgraded star ratings

STAT

UnitedHealth Group is suing the Centers for Medicare and Medicaid Services, asking a judge to halt the federal agency from lowering the insurance company’s 2025 Medicare Advantage quality ratings. The health care giant alleged in the lawsuit that Medicare downgraded its Medicare Advantage star ratings, which are supposed to indicate a plan’s quality, based on “an arbitrary and capricious assessment” of its call center.

330
330
article thumbnail

Latest NHSE workforce survey suggests drop in community pharmacists

The Pharmacist

The latest workforce survey suggests a decrease in the number of qualified pharmacists and pharmacy technicians working in community pharmacy in England between 2022 and 2023. The community pharmacy workforce saw a reduction of 226 qualified pharmacists and 1,108 pharmacy technicians between 2022 and 2023, according to headcount totals recorded by the NHS England (NHSE) […] The post Latest NHSE workforce survey suggests drop in community pharmacists appeared first on The Pharmacist.

article thumbnail

Hospital at Home: Medicare report shows how the experiment is going

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. This week Medicare regulators released a 79-page report on a pandemic-era home hospital program that allowed approved health systems to deliver inpatient care in people’s homes.

Hospitals 302
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Gilead strikes deal to expand HIV drug access in 120 countries

pharmaphorum

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

111
111
article thumbnail

STAT+: Ron Renaud, biotech’s serial CEO, is ready for a new assignment — and maybe another deal?

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. When it comes to delivering shareholder value through M&A, Ron Renaud is a biotech investor’s best friend. Over the last 10 years, all three of the companies he has helmed were sold to Big Pharma for a combined $16 billion.

302
302
article thumbnail

AI pathology accelerates with Proscia Concentriq launch

pharmaphorum

Proscia announces launch of Concentriq Embeddings and Proscia AI Toolkit, hoping to accelerate precision medicine R&D.

111
111
article thumbnail

Dockworker strike puts drug supplies at risk

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. Who gave up fishing on the Cape to run another biotech company? Read on today to find out.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg

Express Pharma

Alembic Pharmaceuticals announced that it has received final approval from the USFDA for its ANDA Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Lamictal XR Extended-Release Tablets, 200 mg, 250 mg, and 300 mg, of GlaxoSmithKline (GSK).

Labelling 110
article thumbnail

STAT+: Pharmalittle: We’re reading about Chinese drugmakers weighing sales, Medicare price talks, and more

STAT

Good day from STAT’s London outpost, with Andrew Joseph here filling in for Mr. Pharmalot. We’re taking the rate at which the sun is setting earlier and earlier as a personal affront, but guess there’s no choice but to keep grinding away, perhaps fueled by an extra cup of stimulation. Maybe some headlines can also do the trick.… Two affiliated Chinese drug manufacturers targeted by forthcoming U.S. national security legislation are working on sales of some of their op

253
253
article thumbnail

Social media algorithms are driving the GLP-1 drugs boom

Pharmaceutical Technology

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.

105
105
article thumbnail

AAPS PharmSci 360 2024: Drug Delivery in Early Development

PharmaTech

Pharmaceutical Technology sat down with Erica Schlesinger, vice president of technical development at Serán Bioscience, to talk about her upcoming presentation at AAPS PharmSci 360 2024, “High Dose Subcutaneous Delivery of Protein Therapeutics.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Research shows NHS, industry partnership benefits patients

pharmaphorum

A new report commissioned by ABPI found hospitals engaging in industry partnerships more likely to follow NICE recommendations.

Hospitals 105
article thumbnail

The Top 10 Longest-Running Drug Patents

Drug Patent Watch

Humira, used to treat various autoimmune diseases, has become the world’s best-selling drug. AbbVie has fiercely protected its patent through a strategy known as “patent thickets,” filing over 100 additional patents related to the drug’s manufacturing process, formulation, and methods of treatment[1].

105
105
article thumbnail

SK pharmteco to strengthen small molecule and peptide capacity with $260 million investment

Outsourcing Pharma

SK Groupâs contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its small molecule and peptide manufacturing muscle in South Korea.

101
101
article thumbnail

Changing Faces – Digital and supplier hires for September 2024

pharmaphorum

Changing Faces – Digital and supplier hires for September 2024 featuring HALIX, Tanvex BioPharma, Avania, Oxford Biomedica, and more. Stay updated on the latest recruitment news and opportunities in the pharmaceutical industry.

100
100
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Social media algorithms are driving the the GLP-1 drugs boom

Pharmaceutical Technology

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might be.

98
article thumbnail

Investment outlook: Key takeaways from LSX USA

pharmaphorum

Discover the key takeaways from the LSX USA Congress with this podcast wrap-up, offering insights into investment outlook and trends discussed at the event.

98
article thumbnail

Tapping the Value of Conscientious Stewardship

Pharmaceutical Commerce

Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.

97
article thumbnail

LoQus23 Therapeutics raises £35m to advance therapy for Huntington’s disease

Outsourcing Pharma

The proceeds of the financing will support the development of LoQus23âs lead candidate, a small molecule inhibitor that is expected to enter the clinic in 2026.

96
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Designing drugs that target "twin" cancer proteins

World Pharma News

Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, with no clear drug-binding sites. To design a drug that blocks a cancer-related protein, Scripps Research scientists took a hint from the protein's paralog, or "twin.

80
article thumbnail

Medicare tweaks rules for second round of drug price talks

BioPharma Dive

The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.

article thumbnail

Express Scripts Sues FTC Over Report on Pharmacy Benefit Management Industry

Big Molecule Watch

On September 17, Express Scripts, Inc. (“Express Scripts”), one of the largest pharmacy benefit managers (PBMs) in the United States, brought suit against the Federal Trade Commission (“FTC”) over its July 2024 interim report on the PBM industry. Express Scripts claims that the FTC’s report, titled “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies,” is defamatory, biased, and based on unfounded accusations.

article thumbnail

BP reshapes its renewable energy strategy

Fuld & Company Blog

BP has embarked on a strategic realignment, reevaluating its renewable energy investments under new leadership, following in Shell’s footsteps. Former CEO Bernard Looney pursued ambitious growth in wind energy, hydrogen, EV charging, and biofuels as part of BP’s transformation into an integrated energy company. However, interim CEO Murray Auchincloss has adopted a more measured approach, focusing on streamlining operations.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.